Tariffs

Policy Briefing

Section 232 Pharma Tariffs Expand Today: What Manufacturers Need to Know

29 September 2026

Policy Briefing

Trump Gives Generic Drugmakers Two Years to Reshore Before Tariffs Hit

22 July 2026

Podcast

Tariffs, FDA Chaos, and BioSecure in Limbo: How CDMOs Should Operate Under Uncertainty

28 June 2026

Chart

82% of Pharma APIs Sourced from China and India — Tariffs Add $20bn to US Costs

9 June 2026

Content

The Politics Behind the Pipeline: How MFN Pricing and Tariffs Are Reshaping Pharma’s Global Strategy

8 June 2026

Policy Briefing

US Pharma Tariffs: 100% Headline Rate, Far Lower Real-World Impact

7 April 2026

Policy Briefing

Trump’s Tariffs Are Off — Or Are They? What Pharma Does Next

23 February 2026

Content

J&J Strikes Drug Pricing Deal with Trump Administration

9 January 2026

Content

US–UK Deal Sets Zero Tariffs, Raises UK Drug Value Thresholds

2 December 2025

Policy Briefing

Trump Administration Launches Review of Global Drug Pricing Practises

23 October 2025